In-vitro diagnostic kits: (1) Abbott Vysis LSI ATM (11q22.3) SpectrmOrange Probe, REF 01N33-020; (2) Abbott Vysis PTEN/CEP 10 FISH Probe Kit, REF 04N62-020; (3) Abbott Vysis TelVysion 1p SpectrumGreen Probe, REF 05J03-001; (4) Abbott Vysis TelVysion 4P SpectrumGreen Probe, REF 05J03-004; (5) Abbott Vysis TelVysion 22q SpectrumOrange Probe, REF 05J04-022;
Published March 6, 2024 · Recall initiated: February 1, 2024
Summary
FDA records medical device Class III recall Z-1189-2024, published March 6, 2024 and initiated February 1, 2024. Recalling firm: Abbott Molecular, Inc.; Status: Ongoing; Reported quantity: 7 kits; Lot: (1) REF 01N33-020 - GTIN 00884999000759, Lot #381411, Exp. 2024-09-22; (2) REF 04N62-020 - GTIN 00884999009301, Lot #382133, Exp. 2024-05-25; (3) REF 05J03-001 - GTIN 00884999009882, Lot #381111, Exp. 2024-06-17; (4) REF 05J03-004 - GTIN 00884999009912, Lot #381102, Exp. 2024-06-17; (5) REF 05J04-022 - GTIN 00884999010451, Lot #530242, Exp. 2024-03-28. Class III means the product is not likely to cause adverse health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Products that were intended for export only which were not approved or registered in accordance with U.S. specifications were shipped to U.S. customers.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Abbott Molecular, Inc.
- Distributor
- US Nationwide distribution in the states of AL, CA, IL, MA, MD, MN, NY, and PA.
- Lot
- (1) REF 01N33-020 - GTIN 00884999000759, Lot #381411, Exp. 2024-09-22; (2) REF 04N62-020 - GTIN 00884999009301, Lot #382133, Exp. 2024-05-25; (3) REF 05J03-001 - GTIN 00884999009882, Lot #381111, Exp. 2024-06-17; (4) REF 05J03-004 - GTIN 00884999009912, Lot #381102, Exp. 2024-06-17; (5) REF 05J04-022 - GTIN 00884999010451, Lot #530242, Exp. 2024-03-28.
- Risk classification
- Class III
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAThe Alinity m System is designed to automate the steps for nucleic acid testing. Model Numbers included inApril 30, 2025
- FDAAbbott Alinity m STI AMP Kit, used with the Alinity m System, product codes: a) REF 09N17-095; b) REFNovember 6, 2024
- FDAAbbott Alinity m HPV AMP Kit, used with the Alinity m System, product codes: a) REF 09N15-095; b) REFNovember 6, 2024
- FDAAlinity m System, Part Number: 08N53-002May 1, 2024
- FDAIn-vitro diagnostic kits: (1) Abbott Vysis MDM2 / CEP 12 FISH Probe Kit, REF 01N15-010; (2) Abbott Vysis LSIMarch 6, 2024
- FDAWash station: M1000 Wash Station Assembly & DITI Slide, REF 04J72-28* (*This part number is a spare to theMarch 6, 2024
Questions about this recall
Was In-vitro diagnostic kits: (1) Abbott Vysis LSI ATM (11q22.3) SpectrmOrange Probe, REF 01N33-020; (2) Abbott Vysis PTEN/CEP 10 FISH Probe Kit, REF 04N62-020; (3) Abbott Vysis TelVysion 1p SpectrumGreen Probe, REF 05J03-001; (4) Abbott Vysis TelVysion 4P SpectrumGreen Probe, REF 05J03-004; (5) Abbott Vysis TelVysion 22q SpectrumOrange Probe, REF 05J04-022; recalled?
Yes. FDA published recall Z-1189-2024 on March 6, 2024. Reported hazard: Products that were intended for export only which were not approved or registered in accordance with U.S. specifications were shipped to U.S. customers.
What should I do if I have this product?
Voluntary: Firm initiated · Letter